STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[8-K] LENSAR, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

LENSAR, Inc. furnished a press release announcing financial results for the fiscal quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 and incorporated by reference.

The information in this report, including Exhibit 99.1, is furnished and not deemed filed under Section 18 of the Exchange Act. The filing also includes Exhibit 104, the cover page interactive data file.

Positive
  • None.
Negative
  • None.
0001320350false00013203502025-11-062025-11-06

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 06, 2025

 

 

LENSAR, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39473

32-0125724

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

2800 Discovery Drive

 

Orlando, Florida

 

32826

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 888 536-7271

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common stock, par value $0.01 per share

 

LNSR

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 2.02 Results of Operations and Financial Condition.

On November 4, 2025, LENSAR, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter ended September 30, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information furnished in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

99.1

Press Release of LENSAR, Inc., dated November 6, 2025

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

LENSAR, Inc.

 

 

 

 

Date:

November 6, 2025

By:

/s/ Nicholas T. Curtis

 

 

Name:

Title:

Nicholas T. Curtis
Chief Executive Officer

 


FAQ

What did LNSR announce in this report?

LENSAR announced financial results for the fiscal quarter ended September 30, 2025, via a press release furnished as Exhibit 99.1.

Which period do the results cover for LNSR?

The results cover the fiscal quarter ended September 30, 2025.

Where can I find LNSR’s detailed results?

They are provided in the press release attached as Exhibit 99.1 and incorporated by reference.

Is the information considered filed with the SEC?

No. The information, including Exhibit 99.1, is furnished and not deemed filed under Section 18 of the Exchange Act.

What exhibits are included with LNSR’s report?

Exhibit 99.1 (press release dated November 6, 2025) and Exhibit 104 (cover page Inline XBRL data file).

What exchange does LNSR trade on?

LNSR common stock is listed on The Nasdaq Stock Market LLC.
Lensar Inc

NASDAQ:LNSR

LNSR Rankings

LNSR Latest News

LNSR Latest SEC Filings

LNSR Stock Data

136.65M
9.58M
19.41%
47.86%
5.14%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ORLANDO